|
1
|
Weisenburger DD, Kim H and Rappaport H:
Mantle-zone lymphoma: A follicular variant of intermediate
lymphocytic lymphoma. Cancer. 49:1429–1438. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berard CW and Dorfman RF: Histopathology
of malignant lymphomas. In: Clinics in HaematologyRosenburg S
(guest ed). 3. W.B. Suanders; London: pp. 39–76. 1974
|
|
3
|
Leonard JP, Williams ME, Goy A, Grant S,
Pfreundschuh M, Rosen ST and Sweetenham JW: Mantle cell lymphoma:
Biological insights and treatment advances. Clin Lymphoma Myeloma.
9:267–277. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrer A, Salaverria I, Bosch F, Villamor
N, Rozman M, Beà S, Giné E, López-Guillermo A, Campo E and
Montserrat E: Leukemic involvement is a common feature in mantle
cell lymphoma. Cancer. 109:2473–2480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tiemann M, Schrader C, Klapper W, Dreyling
MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, et al:
Histopathology, cell proliferation indices and clinical outcome in
304 patients with mantle cell lymphoma (MCL): A clinicopathological
study from the European MCL Network. Br J Haematol. 131:29–38.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelkitli E, Atay H, Yıldiz L, Bektaş A and
Turgut M: Mantle cell lymphoma mimicking rectal carcinoma. Case Rep
Hematol. 2014:6210172014.PubMed/NCBI
|
|
7
|
Doorduijn JK and Kluin-Nelemans HC:
Management of mantle cell lymphoma in the elderly patient. Clin
Interv Aging. 8:1229–1236. 2013.PubMed/NCBI
|
|
8
|
Alwasaidi TA, Hamadah A, Altouri S, Tay J,
McDiarmid S, Faught C, Allan D, Huebsch L, Bredeson C and
Bence-Bruckler I: Outcomes of both abbreviated hyper-CVAD induction
followed by autologous hematopoietic cell transplantation and
conventional chemotherapy for mantle cell lymphoma: A 10-year
single-centre experience with literature review. Cancer Med.
4:1817–1827. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the Committee on Hodgkin's
Disease Staging Classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
10
|
Lai R and Medeiros LJ: Pathologic
diagnosis of mantle cell lymphoma. Clin Lymphoma. 1:197–206. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Banks PM, Chan J, Cleary ML, Delsol G, De
Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG and
Jaffe ES: Mantle cell lymphoma. A proposal for unification of
morphologic, immunologic and molecular data. Am J Surg Pathol.
16:637–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harris NL, Jaffe ES, Stein H, Banks PM,
Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B and
Gatter KC: A revised European-American classification of lymphoid
neoplasms: A proposal from the international lymphoma study group.
Blood. 84:1361–1392. 1994.PubMed/NCBI
|
|
13
|
Harris NL, Jaffe ES, Diebold J, Flandrin
G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD:
The World Health Organization Classification of hematological
malignancies report of the Clinical Advisory Committee Meeting,
Airlie House, Virginia, November 1997. Mod Pathol. 13:193–207.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai R and Medeiros LJ: Pathologic
diagnosis of mantle cell lymphoma. Clin Lymphoma. 1:197–206;
discussion 207–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vose JM: Mantle cell lymphoma: 2013 Update
on diagnosis, risk-stratification and clinical management. Am J
Hematol. 88:1082–1088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rosenwald A, Wright G, Wiestner A, Chan
WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink
HK, Smeland EB, et al: The proliferation gene expression signature
is a quantitative integrator of oncogenic events that predicts
survival in mantle cell lymphoma. Cancer Cell. 3:185–197. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chandran R, Gardiner SK, Simon M and
Spurgeon SE: Survival trends in mantle cell lymphoma in the United
States over 16 years 1992–2007. Leuk Lymphoma. 53:1488–1493. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nygren L, Wennerholm S Baumgartner,
Klimkowska M, Christensson B, Kimby E and Sander B: Prognostic role
of SOX11 in a population-based cohort of mantle cell lymphoma.
Blood. 119:4215–4223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghielmini M and Zucca E: How I treat
mantle cell lymphoma. Blood. 114:1469–1476. 2009. View Article : Google Scholar : PubMed/NCBI
|
